-
Editorial
November 30, 2024
- Editorial for JUO 2024 Vol. 22 No. 3 - Rethinking Urologic Oncology Surgery
- Cheol Kwak
- J Urol Oncol. 2024;22(3):185-187.
Editorial
November 30, 2024
Original Article
November 30, 2024
Original Article
November 30, 2024
Original Article
November 30, 2024
Original Article
November 30, 2024
Brief Report
November 30, 2024
Invited Review
November 30, 2024
Original Article
November 30, 2024
Invited Review
November 30, 2024
Invited Review
November 30, 2024
Review Article
November 30, 2024
Correction
September 11, 2024
Expression of Concern
November 30, 2024
This archive contains links to the full-text of all issues.
![]() |
5,374 | Complex Epidemiology of Prostate Cancer in Asian Countries |
3,666 | Current Update on Prostate Cancer Immunotherapy |
3,318 | Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades |
3,255 | Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up |
3,126 | Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023 |
Cited By 10 |
Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades |
Cited By 9 |
Complex Epidemiology of Prostate Cancer in Asian Countries |
Cited By 3 |
The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials |
Cited By 3 |
Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review |
Cited By 2 |
A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening |